Literature DB >> 19486132

No increased risk of adverse pregnancy outcomes for women with myasthenia gravis: a nationwide population-based study.

J-C Wen1, T-C Liu, Y-H Chen, S-F Chen, H-C Lin, W-C Tsai.   

Abstract

BACKGROUND: This study aims to examine the risk of adverse pregnancy outcomes [low birthweight (LBW), preterm birth, cesarean sections (CS) and babies born small for gestational age (SGA)] in pregnant women with myasthenia gravis (MG), using a 3-year population-based database, taking characteristics of infant and mother into consideration.
METHODS: This study used two nationwide population-based datasets: the Taiwan National Health Insurance Research Dataset and the Taiwan birth certificate registry. We identified 163 pregnant women with MG during 2001-2003 as the study cohort and 815 randomly selected pregnant women as a comparison cohort. Conditional logistic regression analyses were performed.
RESULTS: The results showed that, although these patterns did not reach a statistically significant level, mothers with MG had higher percentages of LBW (6.8%, vs. 5.6%), SGA (17.8%, vs. 14.1%) and cesarean deliveries (44.8%, vs. 37.4%), except for preterm births (8.1%, vs. 8.1%). After adjusting for highest maternal education level, marital status, family monthly income and infant gender and parity, the odds ratios (OR) of LBW, preterm birth, SGA infants, and cesarean delivery for mothers with MG were 1.19 (95% CI = 0.60-2.38), 1.00 (95% CI = 0.54-1.87), 1.30 (95% CI = 0.83-2.04), and 1.33 (95% CI = 0.94-1.88), respectively, as compared to unaffected mothers.
CONCLUSIONS: We conclude that there were no statistically significant differences in the risk of having preterm, LBW, SGA infants and cesarean deliveries between women with and without MG.

Entities:  

Mesh:

Year:  2009        PMID: 19486132     DOI: 10.1111/j.1468-1331.2009.02689.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  7 in total

1.  Intercommunication between the neuroendocrine and immune systems: focus on myasthenia gravis.

Authors:  Jacqueline Mays; Cherié L Butts
Journal:  Neuroimmunomodulation       Date:  2011-09-22       Impact factor: 2.492

2.  Myasthenia gravis: Five new things.

Authors:  Jeffrey M Statland; Emma Ciafaloni
Journal:  Neurol Clin Pract       Date:  2013-04

3.  Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary center and comparison with previous studies.

Authors:  Atakan Tanacan; Erdem Fadiloglu; Gonca Ozten; Ali Can Gunes; Gokcen Orgul; Mehmet Sinan Beksac
Journal:  Ir J Med Sci       Date:  2019-05-09       Impact factor: 1.568

4.  Myasthenia gravis in pregnancy: Systematic review and case series.

Authors:  Harrison Banner; Kirsten M Niles; Michelle Ryu; Mathew Sermer; Vera Bril; Kellie E Murphy
Journal:  Obstet Med       Date:  2022-01-10

Review 5.  Myasthenia Gravis Can Have Consequences for Pregnancy and the Developing Child.

Authors:  Nils Erik Gilhus
Journal:  Front Neurol       Date:  2020-06-12       Impact factor: 4.003

6.  Management of Myasthenia Gravis During Pregnancy: A Report of Eight Cases.

Authors:  Beibei Shi; Linchai Zeng
Journal:  Open Life Sci       Date:  2018-04-06       Impact factor: 0.938

Review 7.  Neuromuscular disorders in pregnancy.

Authors:  Louis H Weimer
Journal:  Handb Clin Neurol       Date:  2020
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.